When we first started this portal, the goal was to bring more stories about the pharmaceutical world to one place. We wanted to have more short articles. There is a thing called syndication of press releases, and we had that, which ran automatically, but we wanted to give it a human touch, so we picked interesting stories and published them separately, connecting the dots and pieces, thus creating more original content.
Soon enough, AI for the average Joe emerged out of nowhere. Cheap chatbots became better than what old Siri used to be, and anybody could simply say, “Hey, AI chatbot, show me today’s news from this or that industry,” and the AI chatbot would gather all the particular industry PRs and pile them up in the chatbox. Suddenly, there was no need for a person to scoop the stories and gather them in one place.
But something is still left for us humans. We can ask questions, and we can compete with AI on various subjects. Just for example, the POTUS gave an order in connection with mandating vaccination in the States—something, to say the least, not in line with his speeches, in which he pretty much sugar-talked to anti-vaxxers (among other kinds of conspiracy theorists). Suddenly, the States are supposed to become better than peer countries in mandating vaccines for children. Now, is anyone asking what’s going on with the anti-vaxxers? Our portal might not be the place to ask those questions. We might not be the best platform to get answers, but somebody should ask that. At least, we think somebody should ask that. We want to ask that. We want that topic to be discussed.
We also think that side stories might be interesting. Today’s readers create their own feeds on the internet; by accepting cookies, they let the algorithms give them the news they want to read. Readers of today seek what they need to read. No one today is limited to reading only stories by a limited number of authors in two or three daily editions, and we mostly don’t buy printed hard copies anymore. Chatbots scoop articles for people of today. So we can serve as a portal to give people at least one more idea.